Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Avonex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

Multiplying options for MS

Recommended pharmacological treatments included one of three interferons (Biogen Idec's Avonex or EMD Serono/Pfizer's Rebif, which are both formulations of interferon ß-1a, or Bayer's Betaseron, an

Biogen Idec appoints new CEO

Biogen Idec has three marketed products: the multiple sclerosis drugs Avonex (interferon beta-1a) and Tysabri (natalizumab), and Rituxan (rituximab), which is approved for non-Hodgkin's lymphoma and rheumatoid arthritis.

Langland dominates IPA Best of Health Awards

Since Mailer. Avonex. Seven Stones. Healthcare Professional, Sales Material  . Get Right in There. ... Avonex. Seven Stones. Healthcare Professional, International Campaign. Delivering Real Measures of Success.

Biogen Idec sues for patent infringement

Bayer, Pfizer and Merck's Serono unit for patent violation, and is claiming royalties on drugs similar to its Avonex (Interferon beta-1a) treatment. ... Last year Avonex accounted for 53 per cent of Biogen Idec's revenue, generating a total of $2.3bn in

Bayer files lawsuit against Teva over Yaz

Bayer is also involved in a lawsuit with Biogen Idec over patent infringement of multiple sclerosis therapy,  Avonex (Interferon beta-1a).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics